
Fintepla: Uses, Instructions, Side Effects, Warnings
Oct 26, 2023 · Fintepla (fenfluramine) is used for the treatment of seizures associated with Dravet syndrome. Includes Fintepla side effects, interactions and indications.
FINTEPLA® (fenfluramine) | Official Patient Website
FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older. It is not known if FINTEPLA is …
Fenfluramine - Epilepsy Foundation
Fenfluramine is the generic name (non-brand name) of a seizure medicine with the brand name Fintepla® from Zogenix.
Fintepla: Uses, Side Effects, Dosage, Interactions, and More
Aug 15, 2024 · Learn about uses, side effects, and more of Fintepla (fenfluramine), which is a prescription oral solution that treats seizures from certain types of epilepsy.
Fintepla (fenfluramine): Uses, Side Effects, Dosage & Reviews
Feb 13, 2023 · Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older. This medication is only meant for those with seizures caused …
Fintepla effectively lowers seizures with Dravet: Real-world ...
Jan 23, 2024 · Fintepla meaningfully lowered seizure frequency over one year in 60% of Dravet syndrome patients treated in a real-world clinical setting.
Fintepla® | UCB
Fintepla® | UCBIn the European Union and in the UK, Fintepla ® is indicated for the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic …
Fintepla dosage: Form, strengths, how to take, and more
Jun 17, 2025 · Fintepla is used in adults and certain children to treat seizures related to Dravet syndrome or Lennox-Gastaut syndrome. Fintepla comes as an oral solution. It’s usually taken …
Fintepla (fenfluramine) - Uses, Side Effects, and More
Feb 5, 2025 · Overview: Fintepla is used to treat certain types of seizures. It may work by blocking certain signals that come from nerves and cause seizures. Common side effects include …
Starting FINTEPLA® | FINTEPLA® (fenfluramine) oral solution
FINTEPLA exhibits agonist activity at serotonin 5-HT2 receptors1 The mechanism by which FINTEPLA exerts its therapeutic effects in the treatment of seizures associated with Dravet …
- Some results have been removed